Clinical Study

A Phase 3 Double-Blind, Placebo Controlled, Parallel Group Study Of A Disease Modifying Agent In Subjects With Early Parkinson Disease

Posted Date: Jun 14, 2017

  • Investigator: Alok Sahay
  • Co-Investigator: Emily Shanks
  • Specialties: Parkinson's Disease, Neurology, Movement Disorders
  • Type of Study: Drug

The purpose of this study is to determine if an investigational drug called isradipine is safe and helpful in slowing the rate of PD decline. Isradipine has been approved by the Food and Drug Administration (FDA) to treat high blood pressure but is consi

Criteria:

You Are Being Asked To Take Part In This Research Study Because You Have Been Diagnosed With Parkinson’S Disease In The Last Three Years, Were At Least 30 Years Old When You Were Diagnosed, And It Is Expected That You Will Not Need Medications To Treat Th

Keywords:

Sahay, Early Stages Of Parkinson's Disease, Newly Diagnosed, Isradipine, Parkinson's Disease

For More Information:

Hilary Perez
(513) 558-0112
hilary.perez@uc.edu

  • Search Clinical Studies

  • Research in the News

    UC Study Finds Organs from HCV Donors May Be Safe for Liver Transplant

    A UC researcher says livers from HCV patients who test positive for theantibody made to fight the disease may pose a modest risk of infection and beacceptable for transplant